DEUTSCHE BANK AG\

Bank

Position in TRVI — Trevi Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in TRVI

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$1,011,126

+$124,298 QoQ

Shares Held

84,755

+19.7% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 1.7981240044835114.ToString("F0")% Shared 0.ToString("F0")% None 98.20187599551649.ToString("F0")%

Healthcare · as of Mar 31, 2026

DEUTSCHE BANK AG\ holds $2,973,467,737 across 247 Biotechnology names. TRVI ranks #132 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,537,736	$686,660,626
2	REGN	Regeneron Pharmaceuticals, Inc.	625,388	$483,199,777
3	ALNY	Alnylam Pharmaceuticals, Inc.	761,464	$251,945,590
4	INCY	Incyte Corp	1,264,195	$118,986,027
5	RPRX	Royalty Pharma plc	2,453,303	$117,684,942
6	ARGX	Argenx SE	139,381	$101,782,972
7	INSM	INSMED Inc	562,474	$91,975,745
8	LGND	Ligand Pharmaceuticals Inc	306,111	$61,115,059

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,011,126	84,755	+19.7%	Shares	Defined	2026-05-06
2025-12-31	$886,828	70,833	+37.2%	Shares	Defined	2026-02-11
2025-09-30	$472,505	51,640	+18.9%	Shares	Defined	2025-11-13
2025-06-30	$237,599	43,437	+15.4%	Shares	Defined	2025-08-12
2025-03-31	$236,666	37,626	+28.7%	Shares	Defined	2025-05-09
2024-12-31	$120,480	29,243	+2.4%	Shares	Defined	2025-06-30
2024-09-30	$95,383	28,558	+105.1%	Shares	Defined	2025-06-26
2024-06-30	$41,490	13,923	-21.9%	Shares	Defined	2025-06-12
2024-03-31	$61,468	17,817	-28.9%	Shares	Defined	2025-06-02
2023-09-30	$54,651	25,070	—	Shares	Defined	2023-11-24
No filing history on record for this holder in this stock.